Publication Name	World Journal of Radiology
Manuscript ID	2464
Country	United States

Received	2013-02-22 09:50
Peer-Review Started	2013-02-22 12:05
To Make the First Decision	2013-03-11 15:06
Return for Revision	2013-03-17 19:33
Revised	2013-04-11 04:06
Second Decision	2013-05-18 16:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-05-19 23:52
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-06-13 18:10
Publish the Manuscript Online	2013-06-26 11:31

ISSN	1949-8470 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Autobiography
Article Title	Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?
Manuscript Source	Invited Manuscript
All Author List	Julia Neperud, Armeen Mahvash, Naveen Garg, Ravi Murthy and Janio Szklaruk
Funding Agency and Grant Number
Corresponding Author	Janio Szklaruk, MD, PhD, Department of Diagnostic Radiology, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States. jszklaru@mdanderson.org
Key Words	Yttrium-90 radioembolization; Computed tomography; Response; Neuroendocrine; Metastases; Liver; Predictor
Core Tip	Treatment modalities for neuroendocrine tumor liver metastases (NETLM) include systemic chemotherapy, surgery, ablation, chemoembolization, and yttrium-90 (90Y) radioembolization. Radioembolotherapy is aimed at delivering high dose of radiation via intra-arterial administration. There are reports of good response rates of NETLM following radioembolization. There are a few reports on the selection criteria based on imaging features. To our knowledge, there are no reports that have evaluated multiple imaging features as selection criteria for 90Y radioembolization. Our goal is to evaluate for a specific imaging feature at presentation that may predict response to treatment. The response will be evaluated using various criteria of tumor response.
Publish Date	2013-06-26 11:31
Citation	Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? World J Radiol 2013; 5(6): 241-247
URL	http://www.wjgnet.com/1949-8470/full/v5/i6/241.htm
DOI	http://dx.doi.org/10.4329/wjr.v5.i6.241

Full Article (PDF)	WJR-5-241.pdf
Manuscript File	2464-Review.doc
Answering Reviewers	2464-Answering reviewers.docx
Copyright License Agreement	2464-Copyright assignment.pdf
Peer-review Report	2464-Peer review(s).pdf
Scientific Editor Work List	2464-Scientific editor work list.doc